ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HILTON GORDON MD

Internal Medicine

510

$8,009

159
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

88%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

THOMAS RUPPERT M.D.

Internal Medicine

1,600

$121K

131
22 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

70%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $60

MICHEL GOWHARI D.O.

Internal Medicine

516

$61.7K

67
0 are 65+

52%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$120
Average prescription price

Avg: $60

MENSUR SUNJE M.D. M.SC.

Internal Medicine

414

$4,513

134
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

62%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$11
Average prescription price

Avg: $60

CHRISTOPHER POTTMEYER M.D.

Internal Medicine

199

$3,379

126
51 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $60

KENNETH MARGULES MD

Internal Medicine

7,820

$488K

408
201 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

54%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

SOHAIL KHAN MD

Internal Medicine

1,270

$89.6K

63
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

60%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $60

GOPAL BHALALA MD

Internal Medicine

10,019

$647K

313
167 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

48%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $60

MARCOS SUNGA MD

Internal Medicine

20,660

$1.33M

485
294 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

PRITH GOOMAR M.D.

Internal Medicine

300

$5,147

76
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $60

VIRENDRA BISLA MD

Internal Medicine

3,264

$205K

209
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

46%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $60

OTUONYE ONYEWUCHI MD, MPH

Internal Medicine

2,135

$101K

160
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $60

SAM GAINES M.D.

Internal Medicine

346

$4,666

213
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $60

OSAMA ATIEH M.D.

Internal Medicine

4,321

$266K

101
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

JALAL DAHSHE MD

Internal Medicine

3,893

$182K

96
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $60

EDWARD RUFUS JR MD

Internal Medicine

12,354

$601K

345
278 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

MARTA BATUS MD

Internal Medicine

840

$420K

90
60 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$500
Average prescription price

Avg: $60

AMER RUSTUM M.D.

Internal Medicine

7,127

$369K

284
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

WILLIAM MOLLOHAN D.O.

Internal Medicine

1,792

$100K

103
38 are 65+

20%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

MARY BROWN MD

Internal Medicine

12,059

$1.06M

332
140 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $60

PAMELA POPE M.D.

Internal Medicine

753

$45.9K

86
42 are 65+

41%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $60

AKIL MOINUDDIN M.D

Internal Medicine

9,419

$523K

275
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

JEROME ANTONY M.D.

Internal Medicine

20,839

$960K

621
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

ISMAIL ATCHA MD FACP

Internal Medicine

8,496

$599K

117
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $60

YELENA SHANCHUK

Internal Medicine

4,181

$230K

170
126 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank